It is a pharma private limited company based in New Delhi, Delhi, India, established in 1984.
1984 | New Delhi, Delhi, India | ActiveNorwest Pharmaceuticals Private Limited, a active private limited company, was established on 28 April 1984 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74899DL1984PTC018048. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.20 M and a paid-up capital of ₹1.12 M.
It upholds a compliant status. Its leadership includes Sandhya Sawhney (Director), Nitin Sawhney (Director). Past directors included Babal Suri, Suresh Kumar Suri. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at E-99Mansarovar Garden, New Delhi, Delhi, 110015.
U74899DL1984PTC018048
018048
28 April 1984
₹1.20 M
₹1.12 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Norwest Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sandhya Sawhney | Director | 16 Aug 2010 | Current |
| Nitin Sawhney | Director | 30 Sep 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Oct 2022 | Past |
| Pramod Abcsdd | Director | 16 Aug 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Norwest Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 45.21% decrease. The company also saw a substantial improvement in profitability, with a 58.69% increase in profit. The company's net worth observed a substantial decline by a decrease of 46.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Norwest Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Norwest Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Norwest Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Norwest Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Norwest Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Norwest Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Progress on Nitin Sawhney was appointed as a Director was appointed as a Director on 30 Sep 2022 & has been associated with this company since 3 years 2 months . was documented.
The activity Sandhya Sawhney was appointed as a Director was appointed as a Director on 16 Aug 2010 & has been associated with this company since 15 years 3 months . was completed.
Progress on Norwest Pharmaceuticals Private Limited was registered on 28 Apr 1984 with Roc Delhi & aged 41 years 7 months as per MCA records. was documented.
The CIN of Norwest Pharmaceuticals Private Limited is U74899DL1984PTC018048.
Norwest Pharmaceuticals Private Limited is headquartered at E-99Mansarovar Garden, New Delhi, Delhi, 110015.
Norwest Pharmaceuticals Private Limited was incorporated on 28 April 1984.
The current directors of Norwest Pharmaceuticals Private Limited are
The primary industry of Norwest Pharmaceuticals Private Limited is Manufacturing.
Norwest Pharmaceuticals Private Limited is unlisted.
The authorized capital of Norwest Pharmaceuticals Private Limited is ₹1.20 M, and the paid-up capital is ₹1.12 M.
The compliance status of Norwest Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX